RaySearch Laboratories has entered biotech deals for its RayStation treatment planning system with Provision Center for Proton Therapy.
The biotech deals with Provision represents a milestone since it is the first proton center to select RayStation since RaySearch and IBA initiated a collaboration in the field of proton therapy earlier this year.
Provision Center for Proton Therapy is one of only 14 proton therapy centers in the United States.
Opening in early 2014, the Center is part of Provision Health Alliance’s comprehensive outpatient cancer treatment campus located in Knoxville, Tennessee.
The comprehensive campus at Dowell Springs is both patient and physician-friendly and is the new model for future healthcare delivery.
RayStation will be implemented for clinical use at Provision Center for Proton Therapy beginning in the first quarter of 2014 as part of the biotech deals.
This will include uniform scanning and passive scattering proton beam planning, IMRT for photons with multi-criteria optimization, as well as cutting edge technologies such as full deformable registration and adaptive re-planning.
Pencil Beam Scanning dose calculation capabilities that will allow for Intensity Modulated Proton Therapy will be introduced sometime in mid-2014.
View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity
View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity